These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 25298163

  • 1. Validity of the Swedish SCID and ADDIS diagnostic interviews for substance use disorders: sensitivity and specificity compared with a LEAD golden standard.
    Gerdner A, Kestenberg J, Edvinsson M.
    Nord J Psychiatry; 2015 Jan; 69(1):48-56. PubMed ID: 25298163
    [Abstract] [Full Text] [Related]

  • 2. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R.
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [Abstract] [Full Text] [Related]

  • 3. Reliability of ADDIS for diagnoses of substance use disorders according to ICD-10, DSM-IV and DSM-5: test-retest and inter-item consistency.
    Gerdner A, Wickström L.
    Subst Abuse Treat Prev Policy; 2015 Apr 02; 10():14. PubMed ID: 25886630
    [Abstract] [Full Text] [Related]

  • 4. [Preliminary comparative study of the personality disorder evaluation DIP instrument with the semi-structured SCID-II interview].
    Massoubre C, Bonnefond H, Grosselin A, Nelva A, Pellet J, Lang F.
    Encephale; 2009 Dec 02; 35(6):544-53. PubMed ID: 20004285
    [Abstract] [Full Text] [Related]

  • 5. Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV).
    Osório FL, Loureiro SR, Hallak JEC, Machado-de-Sousa JP, Ushirohira JM, Baes CVW, Apolinario TD, Donadon MF, Bolsoni LM, Guimarães T, Fracon VS, Silva-Rodrigues APC, Pizeta FA, Souza RM, Sanches RF, Dos Santos RG, Martin-Santos R, Crippa JAS.
    Psychiatry Clin Neurosci; 2019 Dec 02; 73(12):754-760. PubMed ID: 31490607
    [Abstract] [Full Text] [Related]

  • 6. Validity of the SCID in substance abuse patients.
    Kranzler HR, Kadden RM, Babor TF, Tennen H, Rounsaville BJ.
    Addiction; 1996 Jun 02; 91(6):859-68. PubMed ID: 8696248
    [Abstract] [Full Text] [Related]

  • 7. Are clinical impressions of adolescent substance use accurate?
    Wilson CR, Sherritt L, Gates E, Knight JR.
    Pediatrics; 2004 Nov 02; 114(5):e536-40. PubMed ID: 15520086
    [Abstract] [Full Text] [Related]

  • 8. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
    Mestre-Pintó JI, Domingo-Salvany A, Martín-Santos R, Torrens M, PsyCoBarcelona Group.
    Eur Addict Res; 2014 Nov 02; 20(1):41-8. PubMed ID: 23921461
    [Abstract] [Full Text] [Related]

  • 9. Test-retest reliability of psychoactive substance abuse and dependence diagnoses in telephone interviews using a modified Diagnostic Interview Schedule-Substance Abuse Module.
    Aktan GB, Calkins RF, Ribisl KM, Kroliczak A, Kasim RM.
    Am J Drug Alcohol Abuse; 1997 May 02; 23(2):229-48. PubMed ID: 9143636
    [Abstract] [Full Text] [Related]

  • 10. Validity of Chinese Version of the Composite International Diagnostic Interview-3.0 in Psychiatric Settings.
    Lu J, Huang YQ, Liu ZR, Cao XL.
    Chin Med J (Engl); 2015 Sep 20; 128(18):2462-6. PubMed ID: 26365963
    [Abstract] [Full Text] [Related]

  • 11. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN.
    Compton WM, Cottler LB, Dorsey KB, Spitznagel EL, Mager DE.
    Drug Alcohol Depend; 1996 Jul 20; 41(3):179-87. PubMed ID: 8842630
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R.
    Am J Psychiatry; 2006 Apr 20; 163(4):689-96. PubMed ID: 16585445
    [Abstract] [Full Text] [Related]

  • 13. [Sensitivity and specificity between the Composite International Diagnostic Interview Version 3.0 (World Mental Health, CIDI) and the Standardised Clinical Evaluation version I (SCID-I) in a mental health survey of the city of Medellin, 2012].
    Montoya Gonzalez LE, Restrepo Bernal DP, Mejía-Montoya R, Bareño-Silva J, Sierra-Hincapié G, Torres de Galvis Y, Marulanda-Restrepo D, Gómez-Sierra N, Gaviria-Arbeláez S.
    Rev Colomb Psiquiatr; 2016 Apr 20; 45(1):22-7. PubMed ID: 26896401
    [Abstract] [Full Text] [Related]

  • 14. Initial validation of the Russian version of the World Mental Health Structured Clinical Interview for DSM-IV.
    Gutkovich Z.
    Isr J Psychiatry Relat Sci; 2013 Apr 20; 50(1):24-32. PubMed ID: 24029108
    [Abstract] [Full Text] [Related]

  • 15. Consulting for substance abuse: mental disorders among adolescents and their parents.
    Hodgins S, Tengström A, Bylin S, Göranson M, Hagen L, Janson M, Larsson A, Lundgren-Andersson C, Lundmark C, Norell E, Pedersen H.
    Nord J Psychiatry; 2007 Apr 20; 61(5):379-86. PubMed ID: 17990200
    [Abstract] [Full Text] [Related]

  • 16. Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders.
    Kranzler HR, Tennen H, Babor TF, Kadden RM, Rounsaville BJ.
    Drug Alcohol Depend; 1997 Apr 14; 45(1-2):93-104. PubMed ID: 9179511
    [Abstract] [Full Text] [Related]

  • 17. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample.
    Hasin DS, Greenstein E, Aivadyan C, Stohl M, Aharonovich E, Saha T, Goldstein R, Nunes EV, Jung J, Zhang H, Grant BF.
    Drug Alcohol Depend; 2015 Mar 01; 148():40-6. PubMed ID: 25604321
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders.
    Kranzler HR, Kadden RM, Babor TF, Rounsaville BJ.
    J Nerv Ment Dis; 1994 May 01; 182(5):277-83. PubMed ID: 10678309
    [Abstract] [Full Text] [Related]

  • 19. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.
    Hasin D, Shmulewitz D, Stohl M, Greenstein E, Roncone S, Aharonovich E, Wall M.
    Drug Alcohol Depend; 2020 Nov 01; 216():108294. PubMed ID: 33007702
    [Abstract] [Full Text] [Related]

  • 20. Diagnosing comorbidity in substance abusers: a comparison of the test-retest reliability of two interviews.
    Ross HE, Swinson R, Doumani S, Larkin EJ.
    Am J Drug Alcohol Abuse; 1995 May 01; 21(2):167-85. PubMed ID: 7639204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.